| Literature DB >> 31080014 |
Yuan Hu1, Feihong Xu2, Ruihua Zhang2, Diana Legarda2, Jun Dai1, Di Wang2, Heyu Li2, Yao Zhang3, Qingjie Xue1, Guanjun Dong4, Hui Zhang1, Chang Lu5, Arthur Mortha2, Jianguo Liu6, Paolo Cravedi7, Adrian Ting2, Liwu Li3, Chen-Feng Qi8, Susan Pierce8, Miriam Merad2, Peter Heeger9, Huabao Xiong10.
Abstract
Accumulating evidence suggests granulocyte macrophage-colony stimulating factor (GM-CSF) can function as an inflammatory mediator, but whether GM-CSF-producing CD4+ T cells (TH-GM-CSF) are a distinct T helper cell subset is lacking. Herein we demonstrate that interleukin (IL)-1β exclusively drives differentiation of naïve CD4+ T cells into TH-GM-CSF cells via inducing ubiquitination of IL-1 receptor-associated kinase 1 (IRAK1) and subsequent activation of the transcription factor NF-kappaB (NF-κB), independent of RAR-related orphan receptor gamma (RORγt) required for TH17 differentiation. In vivo, TH-GM-CSF cells are present in murine Citrobacter Rodentium infections and mediate colitis following adoptive transfer of CD4+ T cells into Rag1-/- mice via GM-CSF-induced macrophage activation. The TH-GM-CSF cell phenotype is stable and distinct from the TH17 genetic program, but IL-1β can convert pre-formed TH17 cells into TH-GM-CSF cells, thereby accounting for previously reported associations between IL-17 and GM-CSF. Together, our results newly identify IL-1β/NF-κB-dependent TH-GM-CSF cells as a unique T helper cell subset and highlight the importance of CD4+ T cell-derived GM-CSF induced macrophage activation as a previously undescribed T cell effector mechanism.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31080014 DOI: 10.1016/j.jaut.2019.04.010
Source DB: PubMed Journal: J Autoimmun ISSN: 0896-8411 Impact factor: 7.094